» Authors » Satyanarayana R Pondugula

Satyanarayana R Pondugula

Explore the profile of Satyanarayana R Pondugula including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 44
Citations 446
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Salamat J, Ayala E, Huang C, Wilbanks F, Knight R, Akingbemi B, et al.
J Xenobiot . 2024 Sep; 14(3):1256-1267. PMID: 39311150
Leydig cells (LCs) in the testes produce the male sex hormone testosterone (T). Several xenobiotics, including clinical drugs, supplements, and environmental chemicals, are known to disrupt T homeostasis. Notably, some...
2.
Omer S, Pathak S, Mansour M, Nadar R, Bowen D, Dhanasekaran M, et al.
Biomolecules . 2024 Apr; 14(4). PMID: 38672512
In our previous study, we demonstrated the impact of overexpression of CB and CB cannabinoid receptors and the inhibitory effect of endocannabinoids (2-arachidonoylglycerol (2-AG) and Anandamide (AEA)) on canine (...
3.
Desai D, Majrashi M, Pathak S, Almaghrabi M, Liu K, Pondugula S, et al.
Cancer Rep (Hoboken) . 2024 Apr; 7(4):e2074. PMID: 38627904
Background: Iatrogenesis is an inevitable global threat to healthcare that drastically increases morbidity and mortality. Cancer is a fatal pathological condition that affects people of different ages, sexes, and races...
4.
Akinsipe T, Mohamedelhassan R, Akinpelu A, Pondugula S, Mistriotis P, Avila L, et al.
Front Immunol . 2024 Mar; 15:1302587. PMID: 38533507
The breast cancer tumor microenvironment (TME) is dynamic, with various immune and non-immune cells interacting to regulate tumor progression and anti-tumor immunity. It is now evident that the cells within...
5.
Iwaki Y, Lindley S, Bergman N, Smith B, Pondugula S
Front Vet Sci . 2024 Feb; 11:1327377. PMID: 38420207
Introduction: Osteosarcoma (OSA) is an aggressive form of bone cancer in both dogs and humans. The treatment options for metastatic (stage III) OSA are currently limited and the prognosis is...
6.
Ahmed I, Hafiz S, van Ginkel S, Pondugula S, Abdelhaffez A, Sayyed H, et al.
Nat Prod Commun . 2023 Jun; 18(5). PMID: 37292146
Docetaxel (DTX) is the treatment of choice for metastatic castration-resistant prostate cancer. However, developing drug resistance is a significant challenge for achieving effective therapy. This study evaluated the anticancer and...
7.
Liu K, Kadannagari S, Deruiter J, Pathak S, Abbott K, Salamat J, et al.
Life Sci . 2023 May; 326:121752. PMID: 37172818
Bisphenol-S (BPS) is a current substitute for Bisphenol-A (BPA) in various commercial products (paper, plastics, protective can-coatings, etc.) used by all age groups globally. The current literature indicates that a...
8.
Abbott K, Salamat J, Flannery P, Chaudhury C, Chandran A, Vishveshwara S, et al.
ACS Omega . 2022 Oct; 7(38):34034-34044. PMID: 36188260
During multidrug combination chemotherapy, activation of the nuclear receptor and the transcription factor human pregnane xenobiotic receptor (hPXR) has been shown to play a role in the development of chemoresistance....
9.
Zheng H, Daniel J, Salamat J, Mackay L, Foradori C, Kemppainen R, et al.
Endocr Connect . 2022 Jul; 11(8). PMID: 35904237
Glucocorticoids have short- and long-term effects on adrenal gland function and development. RNA sequencing (RNA-seq) was performed to identify early transcriptomic responses to the synthetic glucocorticoid, dexamethasone (Dex), in vitro...
10.
Salamat J, Abbott K, Flannery P, Ledbetter E, Pondugula S
ACS Omega . 2022 Apr; 7(12):9995-10000. PMID: 35382335
Cancer patients often use cannabinoids for alleviating symptoms induced by cancer pathogenesis and cancer treatment. This use of cannabinoids can have unexpected effects in cancer patients depending on the cancer...